Hi Guest
X   

Real-Time Quote

Enter Company or MF 

Nectar Lifesciences Ltd

BSE   |   NSE

532649  NECLIFE  Group (B) BSE data    Add to Watchlist   |  View Tips
    Zoom

How hot is this stock?  © Rediff.com

-40
Price*         
Volume*         
MF holdings         
Sales         
Net profit margin         
  * Computed on last 15 days' trading figures.
Type Numbers Only
Advanced

If you had invested…

Rs ago
You would have
Rs 00,00,00,000.00

* Based on prev close (src - Rediff MoneyWiz)

Report card

AttributeValueDate
PE ratio 5.5422/05/12
EPS (Rs) 3.58Mar, 12
Sales (Rs crore) 396.91Mar, 12
Face Value (Rs)1 
Net profit margin (%) 9.55Mar, 11
Last dividend (%)1012/08/11
Return on average equity14.25Mar, 11

Research centre

Results Statement
Balance sheet - P&L - Cash flow
More
Dividend - Share holding
Capital structures - Ratio

AnnouncementsMore

18 May   Limited Review for March 31, 2012   
14 May   Outcome of Board Meeting   
14 May   Financial Results for March 31, 2012   
17 Feb   Limited Review for Dec 31, 2011   
10 Feb   Financial Results for Dec 31, 2011   
17 Jan   Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992   
12 Jan   Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992   
08 Dec 2011   European cGMP Approval for NecLife's Cephalosporin Formulation Facility   
11 Nov 2011   Financial Results for Sep 30, 2011   
14 Oct 2011   NecLife gets European cGMP Approved for its Oral and Injectables Cephalsporins API Facility   

Compare with

CompanyPrev close
631.90
743.25
924.30
1,660.60
575.80
544.85
110.15
214.30
338.40
414.85

Add Your Stock Call

    Buy        Sell      
         LTP (Rs.)   Close [x]
Time Period
Target (Rs.)
Stop Loss (Rs.)
    
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All Calls

Mutual Fund Selector

Find the fund that is right for you

Create your Portfolio

Track your investments and get daily updates